Plasmatic ADAMTS-13 metalloprotease and von Willebrand factor in children with cyanotic congenital heart disease

Plasmatic ADAMTS-13 metalloprotease and von Willebrand factor in children with cyanotic congenital heart disease

Show other versions (1)

Changes in plasma von Willebrand factor concentration (VWF:Ag) and ADAMTS-13 activity (the metalloprotease that cleaves VWF physiologically) have been reported in several cardiovascular disorders with prognostic implications. We therefore determined the level of these proteins in the plasma of child...

Full description

Bibliographic Details
Main Authors:	R.P.S. Soares, S.P. Bydlowski, N.M. Nascimento, A.M. Thomaz, E.N.M. Bastos, A.A. Lopes
Format:	Article
Language:	English
Published:	Associação Brasileira de Divulgação Científica 2013-04-01
Series:	Brazilian Journal of Medical and Biological Research
Subjects:	ADAMTS-13 von Willebrand factor Congenital heart disease Thrombosis Cardiac surgery
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2013000400375&lng=en&tlng=en

Similar Items

Plasmatic ADAMTS-13 metalloprotease and von Willebrand factor in children with cyanotic congenital heart disease
by: R.P.S. Soares, et al.
Published: (2013-05-01)

PROTEOLYTIC PROCESSING OF VON WILLEBRAND FACTOR BY ADAMTS13 AND LEUKOCYTE PROTEASES
by: Stefano Lancellotti, et al.
Published: (2013-09-01)

ON THE VERSATILITY OF VON WILLEBRAND FACTOR
by: Antoine Rauch, et al.
Published: (2013-07-01)

The role of ADAMTS‐13 and von Willebrand factor in cancer patients: Results from the Vienna Cancer and Thrombosis Study
by: Hanna L. Obermeier, et al.
Published: (2019-07-01)

Von Willebrand factor, ADAMTS13 and mortality in dialysis patients
by: Gurbey Ocak, et al.
Published: (2021-06-01)

The Intriguing Relationships of von Willebrand Factor, ADAMTS13 and Cardiac Disease
by: Benjamin Reardon, et al.
Published: (2021-09-01)

ADAMTS13 and von Willebrand factor assessment in steady state and acute vaso‐occlusive crisis of sickle cell disease
by: Julien Demagny, et al.
Published: (2021-01-01)

Atividade enzimática da ADAMTS-13 e padrão de fragmentação do fator de von Willebrand em crianças hipoxêmicas portadoras de cardiopatias congênitas
by: Natália Mastantuono Nascimento
Published: (2010)

Atividade enzimática da ADAMTS-13 e padrão de fragmentação do fator de von Willebrand em crianças hipoxêmicas portadoras de cardiopatias congênitas
by: Nascimento, Natália Mastantuono
Published: (2010)

Clinical significance of measuring ADAMTS-13, its inhibitor and von Willebrand factor in obstetric and gynecological practice
by: K. N. Grigoreva, et al.
Published: (2021-03-01)

The Influence of Sequence Variation on von Willebrand Factor Biosynthesis, Proteolytic Processing and Clearance
by: Pruss, Cynthia Marie
Published: (2010)

A novel monoclonal antibody against the von Willebrand Factor A2 domain reduces its cleavage by ADAMTS13
by: Lulu Zhang, et al.
Published: (2017-02-01)

Comparison of levels of von Willebrand factor and ADAMTS13 in Patients of Myocardial Infarction and Healthy Controls
by: Shamila Tahir, et al.
Published: (2019-05-01)

The Prognostic Value of ADAMTS-13 and von Willebrand Factor in COVID-19 Patients: Prospective Evaluation by Care Setting
by: Giovanni Tiscia, et al.
Published: (2021-09-01)

Decreased plasma ADAMTS-13 activity as a predictor of postoperative bleeding in cyanotic congenital heart disease
by: Rosangela P.S. Soares, et al.
Published: (2013-04-01)

Age-Associated Increase in Thrombogenicity and Its Correlation with von Willebrand Factor
by: Parnian Alavi, et al.
Published: (2021-09-01)

Pathogenicity of Anti-ADAMTS13 Autoantibodies in Acquired Thrombotic Thrombocytopenic Purpura
by: Mari R. Thomas, et al.
Published: (2015-08-01)

Low ADAMTS13 Activity Correlates with Increased Mortality in COVID-19 Patients
by: Joseph M. Sweeney, et al.
Published: (2021-01-01)

ADAM and ADAMTS Proteases in Hepatic Disorders
by: Dirk Schmidt-Arras, et al.
Published: (2019-02-01)

Von Willebrand Factor and ADAMTS13 in COVID-19 and Beyond: A Question of Balance
by: Emmanuel J Favaloro, et al.
Published: (2021-07-01)

Insights Into Immunothrombosis: The Interplay Among Neutrophil Extracellular Trap, von Willebrand Factor, and ADAMTS13
by: Junxian Yang, et al.
Published: (2020-12-01)

ADAMTS13 gene; a novel splicing site mutation in a case with thrombotic thrombocytopenic purpura
by: Sepideh Zununi Vahed, et al.
Published: (2021-05-01)

Púrpura trombocitopênica trombótica: o papel do fator von Willebrand e da ADAMTS13 Thrombotic thrombocytopenic purpura: the role of von Willebrand factor and ADAMTS13
by: Leandro C. Tonaco, et al.
Published: (2010-01-01)

Severe COVID‐19 is associated with endothelial activation and abnormal glycosylation of von Willebrand factor in patients undergoing hemodialysis
by: Golzar Mobayen, et al.
Published: (2021-08-01)

O fator de von Willebrand, ligação com fator VIII e estudo da atividade da ADAMTS-13 em pacientes com síndrome antifosfolípide primária
by: Natalia Mastantuono Nascimento de Vita
Published: (2014)

O fator de von Willebrand, ligação com fator VIII e estudo da atividade da ADAMTS-13 em pacientes com síndrome antifosfolípide primária
by: Vita, Natalia Mastantuono Nascimento de
Published: (2014)

Influences of ABO blood group, age and gender on plasma coagulation factor VIII, fibrinogen, von Willebrand factor and ADAMTS13 levels in a Chinese population
by: Zongkui Wang, et al.
Published: (2017-03-01)

Enfermedad de von Willebrand adquirida. Aspectos generales Acquired von Willebrand’s disease. General aspects
by: Alina Díaz Concepción
Published: (2004-04-01)

Neutrophil Protease Cleavage of Von Willebrand Factor in Glomeruli – An Anti-thrombotic Mechanism in the Kidney
by: Ramesh Tati, et al.
Published: (2017-02-01)

vWF/ADAMTS13 is associated with on-aspirin residual platelet reactivity and clinical outcome in patients with stable coronary artery disease
by: Ellen M. K. Warlo, et al.
Published: (2017-11-01)

ADAMTS-13 in the Diagnosis and Management of Thrombotic Microangiopathies
by: Galit Sarig
Published: (2014-10-01)

Von Willebrand Factor Multimeric Assay in Acquired von Willebrand Disease Diagnosis: A Report of Experience from North Estonia Medical Centre
by: Marika Pikta, et al.
Published: (2021-06-01)

Shear Stress-Induced Activation of von Willebrand Factor and Cardiovascular Pathology
by: Sergey Okhota, et al.
Published: (2020-10-01)

Recombinant von Willebrand Factor for Pediatric Patient with von Willebrand Disease: First Report in Korea
by: Seoin Kim, et al.
Published: (2021-04-01)

von Willebrand Factor and Platelet Glycoprotein Ib: A Thromboinflammatory Axis in Stroke
by: Frederik Denorme, et al.
Published: (2019-12-01)

Homocisteína plasmática total e fator von Willebrand no diabete melito experimental Total plasmatic homocysteine and von Willebrand factor in experimental diabetes mellitus
by: Renato Delascio Lopes, et al.
Published: (2007-04-01)

Patient with von Willebrand Disease for Gynaecologic Surgery - Perianaesthetic Concerns
by: Rakesh Garg, et al.
Published: (2008-01-01)

Polymorphism in the promoter region of von Willebrand factor gene and von Willebrand disease type 1
by: Daniel Simon, et al.
Published: (2003-12-01)

The Importance and Complications of Sequencing of Von Willebrand Gene in Von Willebrand Disease
by: Zolkova J, et al.
Published: (2019-04-01)

von Willebrand Disease: The diagnosis and management of this bleeding disorder
by: Basim A. Abd, et al.
Published: (2020-01-01)